China Antihypertensive Trial in Acute Ischemic Stroke II
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 4810 participants.
Also called NCT03479554
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 4,810 participants
- Registry
-
NCT03479554
-
- Other papers using this trial's data
- Early Versus Delayed Antihypertensive Treatment After Acute Ischemic Stroke by Hypertension History
- Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial
- Early vs Delayed Antihypertensive Treatment in Acute Single Subcortical Infarction: A Secondary Analysis of the CATIS-2 Randomized Clinical Trial
- Initial systolic blood pressure, antihypertensive treatment timing and outcomes in acute ischemic stroke: a subgroup analysis of CATIS-2 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03479554. Randomized; double masking; primary purpose treatment. Start 2018-06-13 (actual); primary completion 2022-10-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- China Antihypertensive Trial in Acute Ischemic Stroke II
- Acronym
- CATIS-2
- Condition
- Acute Ischemic Stroke
- Intervention (Other)
- Early antihypertensive treatment
- Intervention (Other)
- Delayed antihypertensive treatment
- Lead sponsor
- Tulane University
- Collaborator
- Beijing Tiantan Hospital
- Collaborator
- Soochow University
Record details
- Record id
cardio:ct-nct03479554- Content hash
aed6467fd127ac5c970505edb15bdc2d6148ec8973aedb3a88fecfd7153982d0